48 results
8-K
EX-99.1
BHVN
Biohaven Ltd.
9 May 24
Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments
4:14pm
our Molecular Degrader of Extracellular Protein (MoDE™) technology. We were pleased to report preliminary safety and target engagement data showing … Day at the Yale Innovation Summit on May 29, 2024 in New Haven, CT.”
First Quarter 2024 and Recent Business Highlights
Reported preliminary safety
8-K
EX-1.1
BHVN
Biohaven Ltd.
22 Apr 24
Other Events
4:30pm
to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (“Environmental … to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety alert, “dear doctor” letter, or other notice or action
424B5
BHVN
Biohaven Ltd.
19 Apr 24
Prospectus supplement for primary offering
6:02am
.
Inflammation and Immunology Platform (BHV-1300)
In April 2024, we provided preliminary safety and IgG lowering data from our ongoing single ascending … cohort prior to dosing other subjects. Given BHV-1300’s novel mechanism of action, robust data collection with Safety Review Committee meeting to review
424B5
BHVN
Biohaven Ltd.
17 Apr 24
Prospectus supplement for primary offering
4:01pm
)
In April 2024, we provided preliminary safety and IgG lowering data from our ongoing single ascending dose (“SAD”) study of BHV-1300.
In the study … BHV-1300’s novel mechanism of action, robust data collection with Safety Review Committee meeting to review at least two weeks of follow-up data
8-K
EX-99.1
d7uqw5
15 Apr 24
Regulation FD Disclosure
6:59am
8-K
EX-99.1
byz9pxs45tc4h71ufl7
29 Feb 24
Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
4:16pm
8-K
EX-99.1
y7ly7
8 Jan 24
Regulation FD Disclosure
7:30am
8-K
EX-99.1
yukzl 9yyl93
14 Nov 23
Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments
4:26pm
8-K
EX-1.1
bfvtak4
5 Oct 23
Other Events
4:05pm
424B5
dn1m2gqx372
4 Oct 23
Prospectus supplement for primary offering
4:05pm
8-K
EX-1.1
kg23qx
2 Oct 23
Other Events
9:41pm
424B5
yx6fh
2 Oct 23
Prospectus supplement for primary offering
5:09pm
424B5
5z9c3h847zwldjm6or1e
2 Oct 23
Prospectus supplement for primary offering
5:07pm
8-K
EX-99.1
83dczojz qbmrmmn4
27 Sep 23
Regulation FD Disclosure
6:58am
8-K
EX-99.1
mjol9jomrf4d
31 Jul 23
Biohaven Reports Second Quarter 2023 Financial Results and Recent Business Developments
4:29pm